Sabol Colin R's Form 4 filing
Xylem Inc. (XYL) · filed Jul 20, 2021
- Accession no.
- 0001209191-21-047358
- Filed
- Jul 20, 2021
- Trade date
- Jul 19, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $656.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sabol Colin RCIK 0001531414 | Officer (Senior Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | Common Stock | MOption exerciseAcquired | +1,900 | $48.33 | +$91,827 | 30,975 | Direct | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −1,900 | $116.92F2 | −$222,148 | 29,075 | Direct | |
| Jul 19, 2021 | Common Stock | MOption exerciseAcquired | +1,900 | $48.33 | +$91,827 | 30,975 | Direct | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −1,900 | $117.90F3 | −$224,010 | 29,075 | Direct | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −1,590 | $116.91F4 | −$185,886.9 | 27,485 | Direct | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −205 | $117.90F3 | −$24,169.5 | 27,280 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | Common | MOption exerciseDisposed | −1,900 | $0.00 | $0 | 13,306 | Direct | |
| Jul 19, 2021 | Common | MOption exerciseDisposed | −1,900 | $0.00 | $0 | 11,406 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 Shares were executed at a range of prices from $116.31 to $117.27. 300 Shares were executed at a range of prices from $117.33 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
Referenced by the price of 2 transactions in Table I.
- F4
This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,390 Shares were executed at a range of prices from $116.28 to $117.25. 200 Shares were executed at a range of prices from $117.34 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
Referenced by the price of 1 transaction in Table I.